Arnault Espariat-Tauziede

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 193 publications

Pediatric Orbital Schwannoma Mimicking a Venous-Lymphatic Malformation.

Pediatric Orbital Schwannoma Mimicking a Venous-Lymphatic Malformation.

Journal: Ophthalmology

Published: July 28, 2026

Immunohistochemistry as a tool for identifying PDGFRA amplification in central nervous system tumors.

Immunohistochemistry as a tool for identifying PDGFRA amplification in central nervous system tumors.

Journal: Brain pathology (Zurich, Switzerland)

Published: July 11, 2026

Tectal glioma versus pilocytic astrocytoma: revisiting tumor classification in light of molecular heterogeneity.

Tectal glioma versus pilocytic astrocytoma: revisiting tumor classification in light of molecular heterogeneity.

Journal: Acta neuropathologica

Published: June 20, 2026

Desmoplastic myxoid tumor, SMARCB1-mutant: a case with late recurrence after long-term follow-up.

Desmoplastic myxoid tumor, SMARCB1-mutant: a case with late recurrence after long-term follow-up.

Journal: Free neuropathology

Published: June 06, 2026

New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.

New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.

Journal: Neuropathology and applied neurobiology

Published: January 29, 2026

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Journal: Nature communications

Published: January 09, 2026

CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults.

CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults.

Journal: Neuro-oncology

Published: January 02, 2026

H3K27ME3 loss in diffuse midline gliomas lacking H3K27M or EZHIP expressions, a potential diagnostic pitfall!

H3K27ME3 loss in diffuse midline gliomas lacking H3K27M or EZHIP expressions, a potential diagnostic pitfall!

Journal: Acta neuropathologica

Published: December 23, 2025

BRAFV600E and NRASQ61R Antibodies Are Sensitive and Specific Diagnostic Biomarkers for BRAF and NRAS Mutations in Conjunctival Melanomas.

BRAFV600E and NRASQ61R Antibodies Are Sensitive and Specific Diagnostic Biomarkers for BRAF and NRAS Mutations in Conjunctival Melanomas.

Journal: The American Journal of dermatopathology

Published: December 08, 2025

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Journal: Acta neuropathologica communications

Published: November 15, 2025

DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors.

DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 15, 2025

Pineal alveolar rhabdomyosarcoma with PAX3 fusion: A specific clinico-radio-histomolecular type in the CNS.

Pineal alveolar rhabdomyosarcoma with PAX3 fusion: A specific clinico-radio-histomolecular type in the CNS.

Journal: Journal of neuropathology and experimental neurology

Published: October 09, 2025

Showing 1-12 of 193

Last Updated: 09/26/2026